Porphyrins, porphyrias, cancer and photodynamic therapy - a model for carcinogenesis

Journal of Photochemistry and Photobiology, B: Biology

Volumn 20, Issue 1, 1993, Pages 5-22

  del C Batlle, A M ^a  

^a Facultad de Ciencias Naturales e Instituto M Lillo   (Argentina)

Author keywords

Cancer; Carcinogenesis; Photodynamic therapy; Porphyrias; Porphyrins

Indexed keywords

AMINOLEVULINIC ACID; HEMATOPORPHYRIN DERIVATIVE; PHOTOSENSITIZING AGENT; PHTHALOCYANINE DERIVATIVE; PORPHYRIN;

CARCINOGENESIS; HEME SYNTHESIS; HUMAN; INTRATUMORAL DRUG ADMINISTRATION; PHOTODYNAMIC THERAPY; PORPHYRIA; REVIEW;

AMINOLEVULINIC ACID; HEME; HUMAN; MODELS, BIOLOGICAL; NEOPLASMS; PHOTOCHEMOTHERAPY; PORPHYRIA; PORPHYRINS; SUPPORT, NON-U.S. GOV'T;

EID: 0027321541     PISSN: 10111344     EISSN: None     Source Type: Journal    
DOI: 10.1016/1011-1344(93)80127-U     Document Type: Article

References (166)

1. Tetrapyrole biosynthesis
2. Porphyrins and enzymes of the heme biosynthetic pathway
3. Haem biosynthesis and porphyrias: 50 years in retrospect
4. Molecular hydrogen production by uroporphyrin and coproprophyrin A model for the origin of photosynthetic function
5. The importance of prebiotic porphyrins in biopoiesis
6. Evidence for isomerism in fossil porphyrins of 420–504 molecular weight
7. Porphyrins and phycobilins in precambian rocks
8. The role of heme in the release of iron from transferrine in retyculocytes
9. Hemin control of heme biosynthesis in mouse Friend erythroleukemia cells in culture
10. Genetic metabolic and biochemical aspects of the porphyrias
11. Inhibition by hemin of in vivo translocation of chicken liver 5-aminolaevulinate synthase into mitochondria
12. Key relationship of hepatic heme and iron metabolism: new insights into functions of two old molecules
13. A short story of porphyrins and the porphyrias
14. Die Maematoporphyrie
15. Die Bedenlung der Haematoporphyrinurie in der Physiologie und Pathologie, Ergeb, Allgemein
16. Hydroa aestivale in two brothers complicated with the presence of hematoporphyrin in the urine
17. Uber die sensibilisierende Wirkung tierischer Farbstoffe und ihre physiologische
18. Uber die Wirkung fluoreszierender Stoffe auf Paramaecien
19. Untersuchungen uber die biologische (photodynamische) wirkung des haematoporphyrins und anderen derivate des blut und gallen farbstoffs
20. Regulation of the genes for Heme pathways enzymes in erythroid and in non-erythroid cells - Review
21. The molecular biology of Porphyrias
22. Molecular cloning and sequence analysis of cDNA encoding human ferrochelatase
23. Damage to rat liver mitochondria promoted by delta aminolevulic acid-generated reactive oxygen species: connections with acute intermittent porphyria and lead-poisoning
24. The action spectrum for skin lesions in porphyria cutanea tarda
25. Porphyrins and related compounds as photodynamic sensitizers
26. The photochemical yield of singlet oxygen from porphyrins in different states of aggregation
27. Porphyrin photosensitization of cells
28. Photodynamic membrane damage
29. Activation of the complement system in patients with porphyrias after irradiation in vivo
30. Photodynamic action of porphyrins on aminoacids and proteins I. Selective photooxidation of methionine in aqueous solution
31. Formation of metal complexes of tumor-localizing porphyrins
32. Porphyrin-induced photodamage as related to the subcellular localization of the porphyrins
33. Hematoporphyrin derivative: a possible aid in the diagnosis and therapy of carcinoma of the bladder
34. Photodynamic cell damage and its medical implications
35. Porphyrin localization: a new modality for detection and therapy of tumors
36. Porphyrin photosensitization and phototherapy
37. Porphyrin-sensitized photodynamic inactivation of cells: a review
38. Photosensitizers, therapy and detection of malignant tumors
39. How does photodynamic therapy work?
40. Photochemotherapy of cancer: experimental research — yearly review
41. On porphyria and the aetiology of werevolves
42. Werevolves and vampires
43. A value of erythrocyte protoporphyrin in the diagnosis of latent iron deficiency
44. Sideroblastic anemia
45. 5-Aminolevulic acid synthase activity in developing human erythroblasts
46. Health implications of the hemopoietic effects of lead
47. On the enzymic defects in hereditary tyrosinemia
48. Porphyria pseudoporphyria
49. Acute ethanol ingestion and haem biosynthesis in healthy subjects
50. Etudes sur les aspects offerts par des tumeurs experimentales examinées a$́la lumière de Wood
51. Malignant hepatoma associated with acquired hepatic cutaneous porphyria
52. Lichtdermatose Onder Het Beeld Van Hidroa Vacciniformia op Grond van Intestinale Gezwellvorming (Porphyrinurie)
53. Acquired porphyria from a liver tumor
54. Cutaneous porphyria due to a malignant primary hepatoma
55. Incidence of hepatoma in porphyria cutanea tarda
56. Study of porphyrins present in hepatoma tissue
57. A case of primary liver tumor associated with porphyria
58. Frequence of occurrence of hepatocellular carcinoma in patients with porphyria cutanea tarda in long term follow up
59. Porphyrin metabolism and liver tumors
60. Hepatoma maligno asociado a porfiria cutanea tarda
61. The pathology of liver in porphyria cutanea tarda
62. Association of porphyria cutanea tarda and primary liver cancer. Report of ten cases
63. Porphyria cutanea tarda and hepatocellular carcinoma Frequency and occurrence of related factors
64. A classification of liver tumors occurring in chornic hepatic porphyria
65. Hepatocellular carcinoma in porphyria cutanea tarda: frequency factors related to its occurrence
66. Chronic liver disease in Ethiopia. A clinical study with emphasis on identifying common causes
67. Hepatocellular carcinoma with hepatitis c antibody especificity on a male with porphyria cutanea tarda
68. hepatic porphyria
69. The particular traits of carcinogenesis induced in Wistar rats by aflotoxin B. III. Porphyrins and the activity of gamma-glutamyl—transpeptidase in primary hepatomas and in their tissue of origin
70. Aetiological aspects on primary liver cancer with special regard to alcohol, organic solvents acute intermittent porphyria — an epidemiological investigation
71. Carcinogenic activity of hexachlorobenzene in hampsters
72. Carcinogenesis of hexachlorobenzene in mice
73. Liver cell tumors in rats fed hexachlorobenzene
74. Hexachlorobenzene as a promotor of diethylnitrosamine-initiated hepatocarcinogenesis in rats and comparison with induction of porphyria
75. Porphyria cutanea tarda associated with chronic granulocytic leukemia treated with bisulfan
76. Porphyria cutanea tarda and hematological deseases
77. Acerca de dos nuevos casos de porfiria cutánea tarda infantil en una niña con leucemia y en un niño hemodializado, en tratamiento con S-Adenosil-L-Metionina. Aspectos bioquímicos
78. Porphyria cutanea tarda and chronic myelomonocytic leukemia
79. Porphyria cutanea tarda after allogenic bone marrow transplantation for chronic myelogenous leukemia
80. Erythropoietic protoporphyria, a family study
81. Pseudo-porphyria in a patient with hepatocellular carcinoma
82. Hepatocellular carcinoma in patients with acute intermittent porphyria
83. Porphyrins, porphyrias and hepatocellular cancer
84. Acute hepatic porphyria and hepatocellular carcinoma
85. Primary liver carcinoma in two sisters with acute intermittent porphyria
86. Presence and distribution of free porphyrins in transplants of a chrysoidin-induced mouse hepatoma
87. Protoporphyrin cirrhosis and hepatoma in livers of mice given griseofulvin
88. Porphyrin porphobilinogen and amino ketone levels in tumor tissue
89. Choriocarcinoma associated with phorphobilinogenuria. A case report
90. Porphyria cutanea tarda associated with lymphosarcoma
91. Histography of porphyrins morphologic evaluation of liver punctates
92. Leber und Porphyrin I. Quantitative Bestimmung der Porphyrine in menschlichen
93. Visceral porphyrins in circulatory disorders and tumor disease in humans
94. Comparative porphyrin content in tumors with contiguous non-neoplastic tissues
95. Inter-relationship in porphyrin hormones metabolism
96. Porphyrin biosynthesis in the soybean callus tissue system XV. The effect of growth conditions
97. Adaptation to form bacteriochlorophyll in Rh. Spheroides. Changes in activity of enzymes concerned in pyrrole synthesis
98. Porphyrin synthesis
99. 5-aminolevulinic acid stimulation of porphyrins and hemoglobin synthesis by uninduced Friend erythrocyte leukemia cells
100. Experimental porphyrinopathy: a preliminary report
101. Aberrant porphyrin metabolism in Hepatocellular carcinoma
102. Destruction of erythroleukemic cells by photoactivation of endogenous porphyrins
103. Sequential induction of heme pathway enzymes during erythroid differentiation of mouse Friend leukemia virus infected cells
104. Biosynthese porphyrique dans les globules blancs
105. Biosynthesis of heme in leucocytes
106. 3H-tumors tissues of mice
107. Heme enzymes patterns in rat liver nodules and tumors
108. The effect of griseofulvin on the heme pathway. Studies on tissue explant cultures
109. Porphyrin biosynthesis in human breast cancer. Preliminary minetic in vitro studies
110. Heme biosynthesis in human breast adenocarcinoma — mimetic in vitro studies and some heme enzimic activity levels
111. Rhodanese and ALA-S in mammary tumor and liver from normal and tumor-bearing mice
112. 450 and cytochrome oxidase
113. Mouse mammary carcinoma ALA-D
114. Mouse mammary carcinoma PBGase and hydroxymethyl-bilane synthetase
115. Uroporphyrinogen decarboxylase from mouse mammary carcinoma and liver of normal and tumor-bearing mice
116. Regulation of heme pathway in regenerating mouse liver
117. Heme biosynthesis in a model of precarcinogenesis pre-initiation
118. The heme biosynthetic pathway in the regenerating rat liver. The relation between enzymes of heme synthesis and growth
119. Growth rate determines activity of PBG deaminase in non-malignant and malignant cells
120. The heme biosynthetic pathway in lymphocytes of patients with malignant lymphoproliferative disorders
121. Porphyrin metabolism in some malignant diseases
122. Increased PBG deaminase activity and protoporphyrin content in erythrocytes of patients with primary acquired sideroblastic anemia
123. Photosensitization with derivatives of haematoporphyrin. Review
124. Hematoporphyrin phototherapy Review
125. Photodynamic therapy of cancer
126. Properties and applications of Photodynamic Therapy. Review
127. Cellular uptake and photosensitizing properties of anticancer porphyrins in cell membranes and low and high density lipoproteins
128. Recent developments in anticancer photochemotherapy
129. Phototoxic damage to sebaceous glands and hair follicle of mice after systemic administration of 5-aminolevulic acid correlates with localized protoporphyrin IX fluorescence
130. Photodynamic therapy with endogenous protoporphyrin IX; Basic principles and present clinical experience
131. Fluorescence distribution and photodynamic effect of ALA-induced protoporphyrin IX in the DMH rat colonic tumor model
132. Photodynamic therapy of the normal rat stomach: a comparative study between di-sulphonated aluminium phtalocyanine and 5-aminolevulinic acid
133. Photodestruction of tumor cells by induction of endogeneous accumulation of protoporphyrin IX: enhancement by 1,10-phenanthroline
134. Selective accumulation of endogenously produced porphyrins in a liver metatasis model in rats
135. Differential interaction of porphyrins used in photoradiation therapy with ferrochelatase
136. Tumor-localizing properties of porphyrins. In vitro studies using the porphyrin precursor iminotevulinic acid in free and liposome encapsulated forms
137. Tumor-localizing properties of porphyrins. In vivo studies using free and liposome encapsulated Aminolevulinic acid
138. Intratumoral injection as a more effective means of porphyrin administration for photodynamic therapy
139. Potential of liposome-entrapped aminolevulinic acid in cancer therapy. Effect of prior injection of empty liposomes and different routs of administration
140. Photodynamic action of endogenously synthesized porphyrins from aminolevulinic acid, using a new model for assaying the effectiveness of tumoral cell killing
141. Abnormality of heme synthesis as the initial lesion in carcinogenesis
142. is the initial event in carcinogenesis an enhancement of the mutation rate?
143. Peroxidant states and tumor promotion
144. Free radicals, antioxidant enzymes and carcinogenesis
145. Superoxide radical: an endogenous toxicant
146. Oxidative DNA damage as related to cancer and aging: the assay of thymine glycol and hydrymethyl uracil in human and rat urine
147. Reactive oxygen species are mutagenic to mammalian cells
148. Superoxide radical and hydrogen peroxide in mitochondria
149. Superoxide formation by protoporphyrin as seen by spin trapping
150. Singlet oxygen production by UV and visible photoexcited porphyrins under different states of aggregation
151. Photodynamic generation of hydroxyl radicals by hematoporphyrin derivative and light
152. iron metabolism during infection and neoplasia
153. Hydrogen peroxide cytotoxicity
154. The photodegradation of porphyrins in cells can be used to estimate the life time of singlet oxygen
155. Neonatal exposure to protoporphyrin-activating lighting as a contributing cause of childhood acute lymphocytic leukemia
156. The occurrence of hepatoma in the chronic form of hereditary tyrosinemia
157. Recent advances in metal carcinogenesis
158. Occupational carcinogenesis
159. The metabolism of drugs by hepatic tumors
160. Activities of free radicals metabolizing enzymes in tumors
161. Antioxidant enzymes in normal and transformed mouse liver cells
162. Superoxide dismutase activities in normal murine liver, regenerating liver and H6 hepatoma
163. Kinetics of porphyrin accumulation in cultured epithelial cells exposed to ALA